Manufacturing

4 Dec 20
The electronics sector recorded a marginal 0.1 point rise.
3 Dec 20
The company’s industry business architect shares key benefits of adapting an Industry 4.0 model for manufacturers.
3 Dec 20
Rian discussed how Industry 4.0  can help assist businesses in transforming their processes.
3 Dec 20
The company has achieved high growth and consistent innovation due to strong employee engagement.
17 Nov 20
Both electronic and non-electronic NODX reported declines.
4 Nov 20
It edged up 0.2 point to record a 50.5 expansion, its highest since March 2019.
26 Oct 20
The pharmaceutical cluster’s output more than doubled during the month.
4 Sep 20
It reflects improvements in the manufacturing and electronics sectors.
26 Aug 20
Demand for pharmaceutical stocks is expected to remain strong throughout 2020.
26 Aug 20
Close to 5,100 are for PMETs.
26 Aug 20
Output from all clusters, except precision engineering, dropped.
10 Aug 20
Interim dividend was declared at $0.25 apiece.
6 Aug 20
The bi-directional commercial robot can carry up to 300kg of payload.
5 Aug 20
In line with SIPMM’s results, it was the highest figure recorded in five months.
4 Aug 20
All of its business segments saw an uptick in revenues.
4 Aug 20
Sub-index performances also pointed to an improved external environment.
3 Aug 20
The transport engineering cluster is the most pessimistic as firms expect a weak environment.
27 Jul 20
The transport engineering and biomedical manufacturing led the decline.
10 Jul 20
The rapid growth in international trade in the past few decades has built an incredibly complex global supply chain network.
29 Jun 20
Manufacturing’s growth halted as circuit breaker measures disrupted production.
24 Jun 20
Weak domestic and global demand may force factories to suspend operations.
17 Jun 20
HLA group's subsidiary buys Tasek shares for $57,823.
27 May 20
This is largely attributed to the pharmaceuticals segment which grew 141.3%.
18 May 20
Pharmaceuticals formed bulk of the growth for the month.
13 May 20
The shares are priced at $1.9 apiece.
6 May 20
The company will use the funding to meet growing demand for PHA.
5 May 20
This is said to be the lowest reading since 2008.
30 Apr 20
This sentiment is attributed to weakened external demand and supply chain disruptions.
24 Apr 20
Pharmaceuticals output skyrocketed 126.6%.
21 Jun 17
It successfully produced German quality products for the Asian market.
10 Aug 15
She was responsible for the financial reporting and analysis of the group.
6 Aug 15
Only to be spoiled by declining net margin.
5 Aug 15
He will also chairman of the Nominating Committee and a member of the Audit Committee and Renumaration Committee.
19 Jun 15
The loan was for a recent 24.9% stake acquisition.
9 Mar 15
He was company's CEO from 2009 to 2012.
27 Feb 15
He intended to pursue other interests.
26 Jan 12
Thai floods wreaked havoc to its profitability leading to a worse-than-expected 4Q11 net loss.
25 Jan 12
She will be assistant to the divestment and investments/ M&A fund raising and corporate matters of the Group.
24 Jan 12
Why the glum forecast from Fitch when a demand boom is imminent in 2012?